SPAC1687.07 Antibody

Shipped with Ice Packs
In Stock

Description

Gene Characterization and Functional Insights

SPAC1687.07 is annotated as a conserved fungal protein with a predicted molecular weight of approximately 48 kDa . Its sequence shares homology with proteins involved in cell wall metabolism, particularly β-1,6-glucan synthesis . Studies in S. pombe have linked this gene to:

  • Cell wall organization: Mutations in SPAC1687.07 disrupt β-1,6-glucan formation, leading to defective septum assembly and abnormal cell wall material accumulation .

  • Antifungal resistance: Deletion of SPAC1687.07 confers hypersensitivity to ergosterol biosynthesis inhibitors like clotrimazole and terbinafine .

Experimental Evidence and Antibody Usage

While no specific antibody targeting SPAC1687.07 is referenced in the provided sources, adjacent studies highlight methodologies used to study its function:

  • β-1,3-glucan antibodies: In related research, β-1,3-glucan-specific antibodies (e.g., anti-β-1,3-glucan mouse monoclonal) were used to detect cell wall components in S. pombe .

  • Western blot validation: Antibodies against β-1,3-glucan and β-1,6-glucan (e.g., anti-β-1,6-glucan rabbit polyclonal) are commonly employed to analyze cell wall composition in fission yeast .

Table 1: Functional and Phenotypic Data for SPAC1687.07

CategoryFindingSource
Gene FunctionRequired for β-1,6-glucan synthesis and septum assembly
PhenotypeDeletion causes cell wall defects and septum malformation
Drug SensitivityHypersensitive to ergosterol biosynthesis inhibitors (e.g., clotrimazole)
OrthologsHomologous to Saccharomyces cerevisiae Kre9 (β-1,6-glucan synthesis)

Implications for Antibody Development

  • Epitope selection: Targeting SPAC1687.07’s β-1,6-glucan-binding motifs could enable functional studies.

  • Validation methods: Western blot or immunofluorescence using knockout cell lines (e.g., SPAC1687.07Δ) would confirm specificity .

Research Gaps

  • Antibody specificity: No validated antibody for SPAC1687.07 exists in public databases or commercial catalogs.

  • Functional redundancy: Overlapping roles with other β-glucan synthesis genes (e.g., kre9) may complicate antibody-based studies .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC1687.07 antibody; UPF0357 protein C1687.07 antibody
Target Names
SPAC1687.07
Uniprot No.

Q&A

What is SPAC1687.07 and what cellular processes is it involved in?

SPAC1687.07 is a gene locus in Schizosaccharomyces pombe (fission yeast) that encodes a protein involved in cellular signaling pathways. Based on structural characteristics, this protein appears to be involved in protein-protein interactions that may be regulated through phosphorylation events similar to those observed in TOR complex subunits. In S. pombe, many proteins are multiply phosphorylated and participate in complexes that regulate nutrient signaling and cell growth . When studying SPAC1687.07 using antibodies, researchers should consider its potential involvement in nutrient-responsive pathways and its possible interaction with phosphatidyl inositol kinase (PIK)-related complexes.

What are optimal storage conditions for SPAC1687.07 antibodies?

SPAC1687.07 antibodies should be stored following standard antibody preservation protocols. For short-term storage (1-2 weeks), antibodies can be kept at 4°C. For long-term storage, aliquot the antibody and store at -20°C or -70°C to prevent repeated freeze-thaw cycles that can damage the antibody. Similar to antibodies used in S. pombe research protocols, SPAC1687.07 antibodies should be stored in buffer conditions that maintain stability, typically PBS with 0.1% NaN₃ as described in established protocols . When working with these antibodies, maintain cold chain procedures during experimental handling to preserve antibody function.

What controls should be included when using SPAC1687.07 antibodies?

When using SPAC1687.07 antibodies, include both positive and negative controls to validate experimental results. As a positive control, use wild-type S. pombe extract where SPAC1687.07 is normally expressed. For negative controls, include:

  • Extract from a SPAC1687.07 deletion mutant strain (if available)

  • Pre-immune serum for the same species in which the antibody was raised

  • Secondary antibody-only controls to account for non-specific binding

Similar to work with other S. pombe proteins, preparing controls using trichloroacetic acid extraction methods can prevent proteolysis and maintain protein integrity during experimental procedures . This approach is particularly important when studying potentially phosphorylated proteins like SPAC1687.07, as phosphorylation states can be rapidly modified by cellular phosphatases after cell lysis.

How should I optimize immunoprecipitation conditions for SPAC1687.07?

For successful immunoprecipitation (IP) of SPAC1687.07, optimize buffer conditions and extraction protocols based on the protein's properties. Drawing from established S. pombe IP protocols, prepare soluble whole cell extracts in buffer B by grinding cells in liquid nitrogen . Pre-clear 400 μl of extract (concentration 5 mg/ml) by incubation with prewashed protein G beads rotating for 30 minutes at 4°C.

When using anti-SPAC1687.07 antibodies, add appropriate dilutions (typically 1:150-1:250 for primary antibodies) and incubate rotating at 4°C for 1 hour. After transferring to protein G beads, absorb immunocomplexes by rotating at 4°C for 30 minutes. Perform sequential washes in buffer B followed by buffer B containing 250 mM NaCl to reduce non-specific binding .

For proteins like SPAC1687.07 that may exist in multiprotein complexes, consider using crosslinking agents prior to extraction to preserve protein-protein interactions, particularly if it functions in a manner similar to TOR complex subunits .

What are the best approaches for detecting SPAC1687.07 in subcellular fractionation experiments?

For detecting SPAC1687.07 in subcellular fractions, a chromatin fractionation approach would be appropriate if the protein associates with chromatin or nuclear components. Based on established protocols for chromatin-bound protein analysis in S. pombe , consider the following methodology:

  • Harvest cells during exponential growth (12-14 μm for haploid cells)

  • Perform cell lysis under conditions that preserve protein-chromatin interactions

  • Separate chromatin-bound from soluble fractions through centrifugation

  • Analyze fractions by Western blotting using SPAC1687.07 antibodies

When interpreting results, compare SPAC1687.07 localization under different growth conditions, as many S. pombe proteins show condition-dependent localization patterns. For example, Tor2 protein shows both speckled cytoplasmic localization during vegetative growth and membranous patterns in arrested cells , suggesting that nutrient availability can influence protein distribution.

How can I validate SPAC1687.07 antibody specificity?

To validate SPAC1687.07 antibody specificity, implement a multi-faceted approach:

  • Western blot analysis comparing wild-type and SPAC1687.07 deletion strains (if available)

  • Peptide competition assays, where the antibody is pre-incubated with purified peptide/protein

  • Immunofluorescence microscopy comparing antibody staining patterns with GFP-tagged SPAC1687.07 expressed from its native locus

When analyzing results, be cautious of protein tagging effects, as observed in the COP9/signalosome complex where different tags (HA vs. MYC) resulted in opposite effects on protein stability . The tag length can affect protein degradation, with longer C-terminal extensions potentially protecting proteins from degradation, leading to accumulation differences between tagged variants .

How do mutations in SPAC1687.07 affect rapamycin sensitivity in S. pombe?

If SPAC1687.07 functions in TOR signaling pathways, mutations might influence rapamycin sensitivity similar to known tor2 mutants. The tor2-287 mutant (L2048S substitution) in S. pombe shows hypersensitivity to rapamycin, producing a nitrogen starvation-induced arrest phenotype even in rich media .

To investigate SPAC1687.07's potential role in rapamycin response:

  • Generate point mutations in the protein's catalytic or regulatory domains

  • Test mutant strains for growth on media containing varying rapamycin concentrations

  • Assess recovery from nitrogen starvation in both wild-type and mutant strains

  • Analyze phosphorylation state changes in response to nutrient availability and rapamycin treatment

Monitor cell morphology during these experiments, as rapamycin-sensitive mutants often display characteristic cell cycle arrest phenotypes that can provide insights into the protein's function in nutrient sensing pathways .

What is the impact of epitope tag selection when studying SPAC1687.07 protein interactions?

The choice of epitope tag can significantly impact results when studying SPAC1687.07 protein interactions. Research with S. pombe COP9/signalosome complex revealed that different tags (HA vs. MYC) can produce opposite effects on protein stability . When investigating SPAC1687.07 protein complexes:

  • Compare multiple tagging approaches (N-terminal vs. C-terminal; different tag types)

  • Validate results with antibodies against the native protein when possible

  • Perform size exclusion chromatography to assess complex integrity with different tagged versions

This is particularly important if SPAC1687.07 participates in multiprotein complexes like the TOR complexes, which contain multiple phosphorylated subunits with complex regulatory interactions . Remember that the molecular weight distribution of a protein in size exclusion chromatography can be dramatically affected by the absence of interaction partners, as observed in COP9/signalosome complex subunits .

How can I quantitatively analyze SPAC1687.07 phosphorylation changes during cell cycle progression?

For quantitative analysis of SPAC1687.07 phosphorylation changes:

  • Synchronize S. pombe cultures using standard methods (nitrogen starvation release, lactose gradient, or hydroxyurea block)

  • Collect samples at defined time points throughout the cell cycle

  • Extract proteins using trichloroacetic acid precipitation to preserve phosphorylation states

  • Perform electrophoretic mobility shift assays to detect phosphorylation-dependent migration differences

  • Use phospho-specific antibodies if available, or employ mass spectrometry-based approaches

Mass spectrometry is particularly valuable for identifying specific phosphorylation sites and their occupancy rates. For comprehensive analysis, consider SILAC (Stable Isotope Labeling with Amino acids in Cell culture) approaches that allow direct comparison of phosphopeptide abundances between conditions .

When interpreting results, remember that many S. pombe TOR complex subunits are multiply phosphorylated , and changes in phosphorylation status may reflect not only direct regulation of SPAC1687.07 but also its participation in different protein complexes throughout the cell cycle.

Why might SPAC1687.07 antibody show inconsistent results in immunofluorescence experiments?

Inconsistent immunofluorescence results with SPAC1687.07 antibodies may stem from several factors:

  • Fixation method variation: Different fixation methods can affect epitope accessibility. For S. pombe proteins, paraformaldehyde fixation (3.7% for 30 minutes) followed by cell wall digestion is commonly used . Test multiple fixation protocols to determine optimal conditions.

  • Cell wall digestion efficiency: Incomplete digestion of the S. pombe cell wall prevents antibody access to intracellular antigens. Optimize zymolyase or lysing enzyme concentration and digestion time.

  • Antibody concentration and incubation time: For primary antibodies, dilutions between 1:150-1:250 with overnight incubation at 4°C often yield best results for S. pombe proteins .

  • Protein expression levels: If SPAC1687.07 is expressed at low levels or in a cell cycle-dependent manner, signal may be difficult to detect in asynchronous cultures.

  • Protein localization changes: Like Tor2, which shows different localization patterns in vegetative versus arrested cells , SPAC1687.07 may relocalize under different conditions.

Optimize visualization by using a secondary antibody appropriate for your microscopy setup, such as Cy3-conjugated (1:250) or FITC-conjugated (1:150) antibodies, and view cells after mounting in 90% glycerol containing para-phenylene diamine .

How can I distinguish between specific and non-specific bands when using SPAC1687.07 antibodies in Western blots?

To distinguish between specific and non-specific bands:

  • Use genetic controls: Compare wild-type extracts with those from SPAC1687.07 deletion strains or strains expressing tagged versions of known molecular weight.

  • Perform peptide competition assays: Pre-incubate the antibody with purified SPAC1687.07 protein or peptide epitopes to block specific binding.

  • Analyze multiple strains or conditions: Specific bands should show predictable changes in response to genetic or environmental manipulations that affect the protein.

  • Consider post-translational modifications: If SPAC1687.07 is multiply phosphorylated like TOR complex subunits , it may appear as multiple bands of different molecular weights. Phosphatase treatment of extracts can confirm if bands represent phosphorylated forms.

  • Optimize extraction methods: Use trichloroacetic acid extraction, which prevents proteolysis and preserves protein integrity , reducing artifactual bands from degradation products.

What are the key considerations when developing co-immunoprecipitation protocols for detecting SPAC1687.07 protein interactions?

When developing co-immunoprecipitation (co-IP) protocols for SPAC1687.07:

  • Buffer composition: Optimize salt concentration, detergent type, and detergent concentration to maintain protein-protein interactions while reducing non-specific binding. For S. pombe proteins, buffer B with NaCl concentrations between 100-250 mM has been effective .

  • Cell lysis method: Gentle lysis methods, such as grinding cells in liquid nitrogen, help preserve protein complexes . Avoid harsh detergents that may disrupt weak or transient interactions.

  • Antibody specificity and concentration: Use affinity-purified antibodies when possible to reduce non-specific binding. Titrate antibody amounts to determine optimal concentration for specific immunoprecipitation.

  • Pre-clearing step: Always include a pre-clearing step with protein G beads to reduce non-specific binding to the beads themselves .

  • Crosslinking consideration: For transient interactions, consider using chemical crosslinkers to stabilize complexes before extraction.

  • Quantification approach: To assess the extent of co-immunoprecipitation, compare Western blots of similar amounts of crude extract and depleted extract after precipitation , which allows estimation of the proportion of protein involved in the interaction.

How can CRISPR-Cas9 technology be applied to study SPAC1687.07 function in S. pombe?

CRISPR-Cas9 technology offers powerful approaches for studying SPAC1687.07 function:

  • Precise gene editing: Generate specific point mutations to create alleles similar to the rapamycin-sensitive tor2-287 mutant (L2048S substitution) , allowing investigation of structure-function relationships.

  • Domain deletion/modification: Create truncation or domain-specific mutations to identify functional regions of the protein.

  • Endogenous tagging: Add fluorescent protein tags or epitope tags to the endogenous locus without affecting expression levels or regulatory elements.

  • Conditional knockdown/knockout systems: Develop auxin-inducible degron (AID) tagged versions for rapid protein depletion studies.

  • CRISPRi applications: Use catalytically dead Cas9 fused to repressors to achieve tunable repression of SPAC1687.07 expression.

When designing CRISPR experiments, consider S. pombe's preference for homology-directed repair over non-homologous end joining, which can be leveraged for precise genomic modifications.

What approaches can be used to map the interactome of SPAC1687.07 in different cellular conditions?

To comprehensively map the SPAC1687.07 interactome:

  • BioID or TurboID proximity labeling: Fuse SPAC1687.07 with a biotin ligase to label proximal proteins in living cells, capturing both stable and transient interactions.

  • Quantitative proteomics: Use SILAC or TMT (Tandem Mass Tag) labeling combined with immunoprecipitation to compare interaction partners under different conditions.

  • Chromatin-bound protein analysis: If SPAC1687.07 associates with chromatin, employ techniques similar to ChIP-on-chip approaches to identify both protein interactors and potential DNA binding sites .

  • Yeast two-hybrid screening: Conduct systematic screens using different domains of SPAC1687.07 as bait.

  • Genetic interaction mapping: Perform synthetic genetic array (SGA) analysis to identify genes that functionally interact with SPAC1687.07.

Compare interactomes under different nutrient conditions, as TOR pathway components show condition-dependent interactions related to nutrient availability . This could reveal how SPAC1687.07 functions in different cellular contexts.

How can phosphoproteomic analysis be used to understand SPAC1687.07 regulation and function?

Phosphoproteomic analysis can provide critical insights into SPAC1687.07 regulation:

  • Phosphorylation site identification: Map all phosphorylation sites on SPAC1687.07 using mass spectrometry-based approaches, similar to those used to study TOR complex components which are multiply phosphorylated .

  • Quantitative phosphosite dynamics: Monitor changes in phosphorylation levels across different growth conditions, stress responses, or cell cycle stages.

  • Phosphomimetic and phospho-dead mutations: Generate mutants with specific serine/threonine residues changed to aspartate/glutamate (phosphomimetic) or alanine (phospho-dead) to assess the functional significance of individual phosphorylation events.

  • Kinase and phosphatase identification: Use inhibitor studies or genetic approaches to identify the kinases and phosphatases that regulate SPAC1687.07 phosphorylation.

  • Downstream phosphorylation changes: Analyze how mutations in SPAC1687.07 affect the phosphorylation status of other proteins to place it within signaling networks.

This comprehensive approach can position SPAC1687.07 within the complex regulatory networks that control cell growth and division in response to nutrients and other environmental signals in S. pombe.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.